A
Armando Santoro
Researcher at Humanitas University
Publications - 961
Citations - 56759
Armando Santoro is an academic researcher from Humanitas University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 93, co-authored 847 publications receiving 48505 citations. Previous affiliations of Armando Santoro include Aix-Marseille University & University of Milan.
Papers
More filters
Journal ArticleDOI
Impact of soluble tumor necrosis factor-receptors (stnf-rs) shedding on outcome in patients treated with ngr-htnf
Paolo Andrea Zucali,Matteo Simonelli,F. De Vincenzo,Elena Lorenzi,Armando Santoro,Antonio Lambiase,Claudio Bordignon +6 more
TL;DR: Lambiase et al. as discussed by the authors found that early treatment-induced changes in sTNF-R2 shedding may identify patients who have a greater likelihood of benefit from NGR-hTNF.
Journal ArticleDOI
Aromatase inhibitors in premenopause: Great expectations fulfilled?
TL;DR: In this paper, the use of AIs and GnRH analogues (GnRHa) in early breast cancer was investigated and the results showed that the estrogen blockade obtained by AIs plus GnRHa suppresses circulating estrogens more deeply than tamoxifen plus GNRHa.
Journal ArticleDOI
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study.
Nicola Personeni,Lorenza Rimassa,Claudio Verusio,Sandro Barni,Luca Rubino,Silvia Bozzarelli,Eugenio Villa,Carlo Carnaghi,Maria Chiara Tronconi,Chiara Gerardi,Francesca Galli,Irene Floriani,Annarita Destro,Carlotta Raschioni,Roberto Labianca,Armando Santoro +15 more
TL;DR: Although prospective analysis of PTEN did not allow a validation of the prognostic value of this biomarker, an every second week cetuximab schedule, in addition to first-line FOLFIRI, was effective and well tolerated.
Journal ArticleDOI
Development of an Immobilization Device for Total Marrow Irradiation.
Pietro Mancosu,Pierina Navarria,Ludvig Paul Muren,Luca Castagna,Giacomo Reggiori,Elena Clerici,Barbara Sarina,Stefania Bramanti,Chiara De Philippis,Stefano Tomatis,Armando Santoro,Marta Scorsetti +11 more
TL;DR: The patient positioning shifts for TMI/TMLI irradiation were mitigated by a homemade immobilization system and the use of individualised masks.
Journal ArticleDOI
Pembrolizumab in MMR-proficient metastatic colorectal cancer pharmacologically primed to trigger dynamic hypermutation status: The ARETHUSA trial.
Salvatore Siena,Andrea Sartore-Bianchi,Nicola Personeni,Filippo Pietrantonio,Giovanni Germano,Alessio Amatu,Emanuela Bonoldi,Emanuele Valtorta,Ludovic Barault,Federica Di Nicolantonio,Giulia Siravegna,Giovanni Crisafulli,Lorenza Rimassa,Filippo de Braud,Armando Santoro,Luca Lazzari,Paolo Luraghi,Nabil Amirouchene-Angelozzi,Alberto Bardelli,Silvia Marsoni +19 more
TL;DR: This data indicates that dexamethasone replacement therapy may be a viable treatment option for colorectal cancer with a high tumor mutational burden and high sensitivity to chemotherapy.